Karuna Therapeutics, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Karuna Therapeutics, Inc. annual/quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from 2018 to 2023.
  • Karuna Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was $442M, a 35099% increase year-over-year.
  • Karuna Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $483M, a 43.5% decline from 2022.
  • Karuna Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $856M, a 208% increase from 2021.
  • Karuna Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $278M, a 7486% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $483M -$372M -43.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-22
2022 $856M +$578M +208% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-22
2021 $278M +$274M +7486% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-22
2020 $3.66M -$402M -99.1% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 $405M +$378M +1370% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 $27.6M Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.